M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Olanzapine in Patients With Advanced Cancer and Weight Loss

Phase 1

Completed

Conditions: Weight Loss
Advanced Cancer

Interventions: Drug: Olanzapine

First Posted Date: 2007-06-21

Last Posted Date: 2015-01-08

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 57

Registration Number: NCT00489593

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

SRS Study in Patients With Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Procedure: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2007-06-21

Last Posted Date: 2020-03-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 141

Registration Number: NCT00489008

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Study of Quality of Life for Prostate Proton Therapy

Conditions: Prostate Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-06-21

Last Posted Date: 2020-01-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1125

Registration Number: NCT00489814

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Dexamethasone for Symptom Burden in Advanced Cancer Patients

Phase 2

Active, not recruiting

Conditions: Solid Tumors

Interventions: Drug: Dexamethasone
Drug: Placebo

First Posted Date: 2007-06-21

Last Posted Date: 2024-12-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 132

Registration Number: NCT00489307

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Lyndon Baines Johnson Hospital, Houston, Texas, United States

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors

Not Applicable

Terminated

Conditions: Hypothyroidism
Brain Tumor

Interventions: Drug: Levothyroxine
Drug: Liothyronine

First Posted Date: 2007-06-20

Last Posted Date: 2013-06-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 12

Registration Number: NCT00488644

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

An Exploratory Study on Optical Assessment of Oral Mucositis

Terminated

Conditions: Oral Mucositis
Head and Neck Cancer

Interventions: Procedure: Optical Coherence Tomography
Procedure: Fluorescence Spectroscopy
Behavioral: Pain Scale Questionnaire

First Posted Date: 2007-06-20

Last Posted Date: 2012-07-20

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT00488332

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Molecular Epidemiology of Lymphoma Patients

Withdrawn

Conditions: Lymphoma

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-06-20

Last Posted Date: 2012-02-24

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT00488553

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting

Conditions: Malignant Ovarian Neoplasm
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Carcinoma
Psammocarcinoma
Primary Peritoneal Low Grade Serous Adenocarcinoma
Primary Peritoneal Carcinoma

Interventions: Procedure: Biospecimen Collection
Other: Electronic Health Record Review

First Posted Date: 2007-06-20

Last Posted Date: 2024-08-14

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2000

Registration Number: NCT00488878

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

Phase 2

Active, not recruiting

Conditions: Weight Loss
Advanced Cancer
Anorexia
Insomnia

Interventions: Drug: Mirtazapine
Drug: Placebo

First Posted Date: 2007-06-19

Last Posted Date: 2024-11-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 98

Registration Number: NCT00488072

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

MATCh Parents' Supplemental Survey

Completed

Conditions: Epidemiology

Interventions: Behavioral: Supplemental Survey

First Posted Date: 2007-06-18

Last Posted Date: 2016-02-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1215

Registration Number: NCT00487357

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy